Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xtant Medical Holdings Inc (XTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,828
  • Shares Outstanding, K 13,162
  • Annual Sales, $ 72,200 K
  • Annual Income, $ -70,100 K
  • 60-Month Beta 1.13
  • Price/Sales 0.55
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +249,850.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.72 +8.46%
on 04/02/19
3.50 -15.71%
on 04/05/19
-0.07 (-2.31%)
since 03/22/19
3-Month
2.10 +40.48%
on 01/24/19
4.75 -37.89%
on 03/08/19
+0.74 (+33.48%)
since 01/22/19
52-Week
1.61 +83.23%
on 12/31/18
8.03 -63.26%
on 04/23/18
-5.00 (-62.89%)
since 04/20/18

Most Recent Stories

More News
Report: Developing Opportunities within Weibo, AZZ, Air Industries Group, Moxian, Xtant Medical, and Brainstorm Cell Therapeutics -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Weibo Corporation (NASDAQ:WB),...

AZZ : 45.58 (-2.46%)
AIRI : 1.05 (-2.77%)
BCLI : 3.80 (+0.26%)
MOXCD : 6.5000 (+1.56%)
MOXC : 2.43 (-15.67%)
WB : 72.32 (+1.15%)
XTNT : 2.95 (-1.67%)
Xtant Medical Receives Noncompliance Notice from NYSE American

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from...

XTNT : 2.95 (-1.67%)
Xtant Medical Announces Fourth Quarter and 2018 Financial Results

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results...

XTNT : 2.95 (-1.67%)
Xtant Medical Announces Amendments and Extension of Credit Facility

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has executed the Second...

XTNT : 2.95 (-1.67%)
Xtant Medical to Issue Fourth Quarter and Full Year 2018 Financial Results on April 1, 2019

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial...

XTNT : 2.95 (-1.67%)
Xtant Medical Announces Appointment of New Senior Sales Leaders

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the recent additions of five...

XTNT : 2.95 (-1.67%)
Xtant Medical Announces Appointment of Chief Operations Officer

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin...

XTNT : 2.95 (-1.67%)
Xtant Medical to Issue First Quarter 2018 Results on May 8th, 2018

BELGRADE, MT / ACCESSWIRE / May 2, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it...

XTNT : 2.95 (-1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade XTNT with:

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Key Turning Points

2nd Resistance Point 3.06
1st Resistance Point 3.01
Last Price 2.95
1st Support Level 2.89
2nd Support Level 2.82

See More

52-Week High 8.03
Fibonacci 61.8% 5.58
Fibonacci 50% 4.82
Fibonacci 38.2% 4.06
Last Price 2.95
52-Week Low 1.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar